Traditional Chinese medicine for preventing and treating hyperglycemia
A high blood sugar, traditional Chinese medicine technology, used in traditional Chinese medicine for diabetes, and the field of prevention and treatment of high blood sugar with Shenjincao, can solve the problems of only temporary control, exhaustion lesions, difficult to cure with drugs, etc., to achieve normal blood sugar and lower blood sugar levels. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0022] Embodiment 1: A kind of traditional Chinese medicine for preventing and treating hyperglycemia is composed of the following raw material formulas in parts by weight: 10-20 parts by weight of C. Asparagus 5-10.
[0023] Method of administration: The above medicinal materials are made into traditional Chinese medicine powder or capsule according to the conventional preparation process, and taken three times a day, 4-8 grams each time.
Embodiment 2
[0024] Embodiment 2: A traditional Chinese medicine for preventing and treating hyperglycemia, which is composed of the following raw material formula in parts by weight: 10 Herba chinensis, 10 Plumeria japonica, 3 licorice, 5 Cuscuta chinensis, 10 Poria cocos, 5 Ophiopogon japonicus.
[0025] The method of taking is the same as in Example 1.
Embodiment 3
[0026] Embodiment 3: A kind of traditional Chinese medicine for preventing and treating hyperglycemia, which is composed of the following raw material formulas in parts by weight: 10-20 parts by weight of C. Mendong 5-10, rush 3-5, ebony 3-10.
[0027] The method of taking is the same as in Example 1.
[0028] Clinical observation effect of the present invention:
[0029] 1.1 General information: 60 outpatients with type 2 diabetes in the Municipal People's Hospital were selected and randomly divided into two groups. The treatment group included 30 cases, including 16 males and 14 females, aged 30 to 70 years, with an average of (50±1.5) years, and a course of disease of 6 months to 15 years, with an average of (8.0±1.2) years; 30 cases in the control group, 18 males Cases, 12 females, aged 29 to 70 years. There was no statistically significant difference in general data between the two groups (P>0.05), and they were comparable.
[0030] 1.2 Case selection: Refer to the 1...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com